Unlocking the Power of Novel HER3-Targeting Agents in NSCLC and Breast Cancer: Expert Insights and Considerations for Precision Care

Read a Call to Action commentary, view CME-certified microlearning text modules, download slidesets, and listen to a podcast conversation on HER3, a novel therapeutic target under investigation in multiple solid tumor types, from an expert panel including specialists in breast and lung cancers.

Share

Program Content

Activities

HER3 ADC commentary
HER3-Targeted Antibody–Drug Conjugates for Lung and Breast Cancers: Where We Are Today
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2023

Activities

HER3 Breast Text Module
Elevating the Science of HER3-Targeted Therapy to Improve Outcomes in Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2023

Expires: October 12, 2024

HER3 Rationale Text Module
Expanding Our Understanding of HER3 Expression, Implications, and Rationale for HER3-Targeted Therapy in Solid Tumors
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

Expires: October 19, 2024

HER3 NSCLC Text Module
Exploring the Clinical Landscape of Novel HER3-Targeted Treatments for Advanced NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2023

Expires: November 05, 2024

Activities

HER3 Breast Slideset
Elevating the Science of HER3-Targeted Therapy to Improve Outcomes in Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2023

HER3 Rationale Slideset
Expanding Our Understanding of HER3 Expression, Implications, and Rationale for HER3-Targeted Therapy in Solid Tumors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

HER3 NSCLC Slideset
Exploring the Clinical Landscape of Novel HER3-Targeted Treatments for Advanced NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2023

Activities

HER3 Podcast
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.